Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
72.00
-0.68 (-0.94%)
Nov 13, 2026, 4:00 PM EST - Market closed

Monopar Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
52.6361.8345.827.278.1920.3
Short-Term Investments
76.8178.5714.4-4.93-
Cash & Short-Term Investments
129.45140.460.217.2713.1220.3
Cash Growth
-9.90%133.17%728.67%-44.62%-35.38%21.31%
Other Current Assets
0.430.060.080.070.050.22
Total Current Assets
129.88140.4660.297.3313.1720.52
Property, Plant & Equipment
0.370.25-0.010.06-
Total Assets
130.25140.7260.297.3513.2320.52

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2.822.642.251.763.131.58
Accrued Expenses
--3---
Current Portion of Leases
0.160.09----
Total Current Liabilities
2.982.745.251.763.131.58
Long-Term Leases
0.20.15--0.01-
Total Liabilities
3.182.895.251.763.141.58

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.0100.010.01
Additional Paid-In Capital
231.88227.2130.7965.8161.8760.22
Retained Earnings
-104.91-89.51-75.79-60.21-51.8-41.29
Comprehensive Income & Other
0.10.130.04-0.010.01-0
Total Common Equity
127.07137.8355.045.5910.0918.94
Shareholders' Equity
127.07137.8355.045.5910.0918.94
Total Liabilities & Equity
130.25140.7260.297.3513.2320.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.360.25--0.01-
Net Cash (Debt)
129.09140.1560.217.2713.1120.3
Net Cash Growth
-10.09%132.77%728.67%-44.58%-35.42%21.31%
Net Cash Per Share
15.1118.9115.892.635.158.14
Filing Date Shares Outstanding
6.786.696.113.492.642.52
Total Common Shares Outstanding
6.766.696.12.982.592.52
Working Capital
126.9137.7355.045.5810.0418.94
Book Value Per Share
18.7920.609.021.873.907.52
Tangible Book Value
127.07137.8355.045.5910.0918.94
Tangible Book Value Per Share
18.7920.609.021.873.907.52
SEC Filings: 10-K · 10-Q